Patents Represented by Attorney, Agent or Law Firm Maryellen Feehery
  • Patent number: 6955825
    Abstract: A composition and method for delivering sulfur to skin and absorbing irritants in the skin. A high sorption base is employed which comprises non-swelling clay, gum, swelling clay, silicon and combinations thereof. The absorption of the irritants does not hinder the delivery of the active ingredient to the skin.
    Type: Grant
    Filed: April 21, 2004
    Date of Patent: October 18, 2005
    Assignee: Medicis Pharmaceutical Corporation
    Inventors: Jonah Shacknai, Eugene H. Gans
  • Patent number: 6787160
    Abstract: A composition and method for delivering sulfur to skin and absorbing irritants in the skin. A high sorption base is employed which comprises non-swelling clay, gum, swelling clay, silicon and combinations thereof. The absorption of the irritants does not hinder the delivery of the active ingredient to the skin.
    Type: Grant
    Filed: December 20, 2002
    Date of Patent: September 7, 2004
    Assignee: Medicis Pharmaceutical Corporation
    Inventors: Jonah Shacknai, Eugene H. Gans
  • Patent number: 6765001
    Abstract: The present invention comprises a composition, method of enhancing potency and method of delivering corticosteroids in a vehicle comprising at least two penetration enhancers, and solvents and emulsifiers. The propylene glycol and penetration enhancers are present in ratio to the total of the propylene glycol, penetration enhancers, and solvents and emulsifiers of at least about 0.70.
    Type: Grant
    Filed: December 21, 2001
    Date of Patent: July 20, 2004
    Assignee: Medicis Pharmaceutical Corporation
    Inventors: Eugene H. Gans, Mitchell S. Wortzman
  • Patent number: 6727365
    Abstract: The present invention relates to an improved eco-friendly process for the preparation of vinylpyridine from corresponding picoline over modified zeolite catalyst in vapour phase which comprises reacting picoline with formaldehyde with a molar ratio of formaldehyde to picoline in the range of 1:1 to 4:1, at a temperature ranging between 200° C. to 450° C., at a weight hourly in the range of 0.25 hr−1-1.00 hr−1 over a modified commercial zeotlite catalyst to obtain a high yield and selectivity of the desired product.
    Type: Grant
    Filed: October 31, 2002
    Date of Patent: April 27, 2004
    Inventors: Shivanand Janardan Kulkarni, Gangapuram Madhavi, Venkataraman Viswanathan, Kondapuram Vi jaya Raghavan
  • Patent number: 6727228
    Abstract: The present invention relates to compositions and methods for administering compositions in solutions for killing adult lice and the ova comprising water, PVM/MA Decadiene crosspolymers, propylene glycol, a mixture of cetyl and stearyl alcohols, Ceteareth-20; stearalkonium chloride; benzyl alcohol; hexylene glycol; pentylene glycol, isopropyl alcohol; a mixture of spinosyn A and spinosyn D in a weight ratio of 80:20, BHT; and sodium hydroxide.
    Type: Grant
    Filed: April 25, 2001
    Date of Patent: April 27, 2004
    Assignee: Johnson & Johnson Consumer Companies, Inc.
    Inventors: Herwig Janssen, Kie Ho, Glenn Nystrand, Dexter Williams, C. Scott Lamb
  • Patent number: 6677463
    Abstract: The present invention provides a single pot process for the preparation of artesunic acid from artemisinin involving reduction followed by esterification of the reduced product at room temperature.
    Type: Grant
    Filed: December 10, 2002
    Date of Patent: January 13, 2004
    Assignee: Council of Scientific and Industrial Research
    Inventors: Rajendra Singh Bhakuni, Atul Prakash Kahol, Tarun Singh, Suman Preet Singh Khanuja
  • Patent number: 6586473
    Abstract: A topical composition for delivering an effective amount of a pharmaceutically acceptable drug, including laureth-4, propylene glycol, dimethylsorbide, and a pharmaceutically acceptable diluent is described as an improved drug delivery composition. Further, a method of transepithelial delivery of a drug to a human by topical application to the skin of a human of a composition including laureth-4, propylene glycol, dimethylsorbide, a pharmaceutically acceptable diluent of water and ethanol and an effective amount of a pharmaceutically acceptable drug has beneficial delivery effects.
    Type: Grant
    Filed: January 12, 2000
    Date of Patent: July 1, 2003
    Assignee: Medicis Pharmaceutical Corporation
    Inventors: Thomas P. Nigra, Eugene H. Gans
  • Patent number: 6514489
    Abstract: A method for reducing the production of malodor in sulfur containing dermatological compositions by adjusting the pH of the composition to between about 6.5 to about 8.1. Also, sulfur containing dermatological compositions having a pH between about 6.5 and about 8.1.
    Type: Grant
    Filed: June 30, 2000
    Date of Patent: February 4, 2003
    Assignee: Medicis Pharmaceutical Corp.
    Inventors: Jonah Shacknai, Eugene H. Gans, Ray Figureoa
  • Patent number: 6282550
    Abstract: A method for providing information to a customer who is requesting a synthesized oligonucleotide, peptide, peptide nucleic acid, polysaccharide or antibody (collectively “strands”). The capabilities of one or more suppliers are stored and automatically searched for capabilities to synthesize the requested strand. A list of the suppliers with the required capabilities is generated along with the price of the strand. The invention also encompasses an apparatus for providing information to remote users regarding which suppliers can supply a desired strand. The apparatus has a database and a server which allows the remote user to access the capabilities of one or more suppliers for synthesizing a strand.
    Type: Grant
    Filed: January 10, 2000
    Date of Patent: August 28, 2001
    Assignee: Tangerine Technologies, Inc.
    Inventors: Jay Raman Venkatesan, Todd Riley Johnson, Joshua David Lynn, Eric Christopher Parkinson
  • Patent number: 6028105
    Abstract: A topical composition for delivering an effective amount of a pharmaceutically acceptable drug, including laureth-4, propylene glycol, dimethylsorbide, and a pharmaceutically acceptable diluent is described as an improved drug delivery composition. Further, a method of transepithelial delivery of a drug to a human by topical application to the skin of a human of a composition including laureth-4, propylene glycol, dimethylsorbide, a pharmaceutically acceptable diluent of water and ethanol and an effective amount of a pharmaceutically acceptable drug has beneficial delivery effects.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: February 22, 2000
    Inventor: Thomas P. Nigra